Page 76 - MemoriaCIBER-2017ENG

CIBERHEP Chronic Hepatitis B
Coordinator: David Tabernero Caellas
The chronic hepatitis B platform CIBERHEP is a cooperation scheme between the CIBER and the Aso- ciación Española para el Estudio del Higado (AEEH) At the present time this is the main database for patients being treated for chronic hepatitis B in Spain In 2016 the database and its associated web page were updated, thus extending the data collected to carry out more exhaustive studies on the follow-up of patients in antiviral treatment with entecavir (ETV) and tenofovir (TDF), especially focussing on safety and side-e ects of these, at the same time as simplifying the recording of this data
In 2017, they proceeded to check patients already registered in the databases for updating this new data collected Hence, up to now 1464 patients treated with analysable data have been entered in the database, monitored at 27 centres in 9 di erent regional administrative areas 388 of these are being treated with ETV, 897 with TDF and 23 with both The review and updating of this data has enabled us to carry out studies whose main conclusions were: 1) A high percentage of subjects with chronic hepatitis B would bene t from treatment with TAF in renal clinical practice; 2) Low rate of clinical and adverse renal events in subjects with chronic hepatitis B in treatment with TDF or ETV in clinical practice These studies were recently sent as summaries to the national congress of the Sociedad Española de Pa- tología Digestiva
Furthermore, in 2017 the results of the validation of the PA- GE-B marking system in the Spanish pop- ulation of patients with chronic hepatitis B in antiviral treatment and analysis of the e ectiveness and renal safety of ETV and TDF in this cohort of patients were published in journal Digestive Diseases and Sciences [Riveiro-Barciela, M , Tabernero, D , Calleja, J L et al Dig Dis Sci (2017) doi:10 1007/ s10620- 017-4448-7]
e-CATCH Diagnosis and advice for treatment of liver cancer
Coordinator: Jordi Bruix Tudó
The e-Catch platform aims to o er diagnostic and therapeutic orientation services in patients with liver cancer by means of electronic enquiries The possibility of evaluating both reports and imaging tech- niques enables reviewing the information available by the doctors that they consult on a reliable basis and giving guidance based on scienti c evidence In 2016 a contract was established with the pharma- ceutical company Bayer, which nanced the telemedicine activity
In 2017 over 50 consultations were made over the platform Apart from the consultancy services, the platform has enabled transporting tomography or resonance images in order to validate the results of multi-centre studies and thus to guarantee the validity of the image readings by independent radiolo- gists
76 CIBER ANNUAL REPORT 2017